Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages

Xionghui Ding1,2, Hiroto Kambara1, Rongxia Guo1,3

  • 1Department of Pathology, Dana-Farber/Harvard Cancer Center, Harvard Medical School; Department of Laboratory Medicine, Boston Children's Hospital, Enders Research Building, Room 814, Boston, MA, 02115, USA.

Nature Communications
|November 19, 2021
PubMed

Insights

Disrupting GSDMD, a cell death mediator, surprisingly improves survival in mice with fungal sepsis caused by Candida albicans. This strategy blocks fungal escape from immune cells while preserving protective inflammation.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • * Candida albicans is a primary cause of fungal sepsis.
  • * Inflammasome inhibition protects against some sepsis types but may worsen Candida infections.
  • * GSDMD is a key mediator of pyroptosis, a form of programmed cell death.

Purpose of the Study:

  • * To investigate the role of GSDMD in Candida albicans sepsis.
  • * To explore GSDMD inhibition as a potential therapeutic strategy for candidiasis.

Main Methods:

  • * Used a mouse model of Candida albicans infection.
  • * Assessed the impact of GSDMD disruption on survival and fungal dissemination.
  • * Investigated the mechanisms of fungal escape from macrophages.

Main Results:

  • * GSDMD disruption improved survival and outcomes in mice with candidiasis.
  • * Candida albicans utilizes the inflammasome-GSDMD pathway to escape macrophages via hyphae and candidalysin.
  • * GSDMD inhibition prevented fungal escape and maintained IL-1β production.

Conclusions:

  • * GSDMD plays a critical role in Candida albicans' evasion of host immunity.
  • * Inhibiting GSDMD offers a novel therapeutic approach for Candida sepsis.
  • * GSDMD-independent IL-1β production is crucial for anti-fungal defense.